Find clinical trials for Ovarian Cancer in Jacksonville, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Jacksonville, FL, USA:
efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...
Phase 2
Jacksonville, Florida, United States and 20 other locations
as "study drug". The study is focused on patients who have advanced ovarian cancer.The aim of the study is to see how safe, tolerab...
Phase 2
Jacksonville, Florida, United States and 23 other locations
A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer....
Phase 2
Jacksonville, Florida, United States and 41 other locations
This study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With C...
Phase 2
Jacksonville, Florida, United States and 81 other locations
, which are pieces of a protein known as "folate receptor alpha" (FRalpha), a protein that is found in high levels on ovarian cancer...
Phase 1, Phase 2
Jacksonville, Florida, United States and 2 other locations
Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...
Phase 3
Jacksonville, Florida, United States and 179 other locations
This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance treatment in participants with Stage III or IV ovarian cancer...
Phase 3
Jacksonville, Florida, United States and 199 other locations
as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high fola...
Phase 3
Jacksonville, Florida, United States and 265 other locations
following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...
Phase 3
Jacksonville, Florida, United States and 237 other locations
T cell therapy product genetically engineered to express an HLA-A\*02:01-restricted T cell receptor (TCR), targeting TP53 R175H mutant solid tumors...
Phase 1
Jacksonville, Florida, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal